Missed GME or NVDA? Don’t Miss the Next One.​
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
Home › Stocks › Abacus Life Inc. (ABL) Stock Forecast & Price Prediction United States | NASDAQ | Financial Services | Insurance - Life
$8.19
-0.23 (-2.73%)10 Quality Stocks Worth Considering Now
Researching Abacus Life (ABL) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on ABL and similar high-potential opportunities.
Based on our analysis of 5 Wall Street analysts, ABL has a bullish consensus with a median price target of $14.00 (ranging from $12.00 to $15.00). The overall analyst rating is Strong Buy (9.2/10). Currently trading at $8.19, the median forecast implies a 70.9% upside. This outlook is supported by 5 Buy, 0 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Matt Howlett at B. Riley Securities, projecting a 83.2% upside. Conversely, the most conservative target is provided by Crispin Love at Piper Sandler, suggesting a 46.5% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for ABL.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
May 9, 2025 | Piper Sandler | Crispin Love | Overweight | Maintains | $12.00 |
Apr 29, 2025 | Maxim Group | Buy | Initiates | $14.00 | |
Apr 8, 2025 | Piper Sandler | Crispin Love | Overweight | Maintains | $11.50 |
Jan 7, 2025 | B. Riley Securities | Matt Howlett | Buy | Maintains | $15.00 |
Nov 25, 2024 | B. Riley Securities | Matt Howlett | Buy | Maintains | $17.00 |
Nov 8, 2024 | Piper Sandler | Crispin Love | Overweight | Reiterates | $13.00 |
Oct 24, 2024 | Northland Capital Markets | Mike Grondahl | Outperform | Initiates | $13.50 |
Aug 29, 2024 | B. Riley Securities | Matt Howlett | Buy | Reiterates | $16.00 |
Aug 7, 2024 | TD Cowen | Andrew Kilgerman | Buy | Initiates | $14.00 |
Jun 26, 2024 | Piper Sandler | Crispin Love | Overweight | Initiates | $12.00 |
Jun 24, 2024 | B. Riley Securities | Matt Howlett | Buy | Reiterates | $15.00 |
May 31, 2024 | B. Riley Securities | Matt Howlett | Buy | Initiates | $16.00 |
The following stocks are similar to Abacus Life based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Abacus Life Inc. has a market capitalization of $789.43M with a P/E ratio of 66.9x. The company generates $111.92M in trailing twelve-month revenue with a -21.4% profit margin.
Revenue growth is +40.2% quarter-over-quarter, while maintaining an operating margin of -22.8% and return on equity of -8.5%.
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Specializes in life settlement solutions.
The company purchases and manages life insurance policies, allowing policyholders to sell their policies for immediate cash. This business model provides a financial planning tool, especially for seniors who may no longer require or afford their insurance coverage, thereby generating revenue through the acquisition and management of these policies.
Abacus Life Inc. plays a significant role in enhancing financial independence for policyholders and operates at the nexus of personal finance and insurance services. Its operations impact various sectors, including estate planning, retirement financing, and wealth management, positioning the company as a key player in the evolving landscape of life settlements.
Financial Services
Insurance - Life
157
Mr. Jay J. Jackson
United States
2023
Abacus Life, Inc. (ABL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Abacus Global Management (NASDAQ: ABL) reported Q1 fiscal 2025 adjusted EPS of $0.18, surpassing estimates of $0.16, fueled by record capital deployment and strong performance in life settlements.
Abacus Global Management's strong Q1 earnings and growth in life settlements signal robust performance, enhancing investor confidence and potentially driving stock appreciation.
Abacus Global Management (NASDAQ: ABL) will host a virtual Investor Day and Longevity Summit on June 12, 2025, at 9:30 AM ET.
The Abacus Investor Day and Longevity Summit could reveal strategic insights and performance updates, influencing stock performance and investor sentiment for ABL shares.
Abacus Life, Inc. (ABL) and Annaly Capital Management (NLY) have been compared to their sector's performance year-to-date. Specific performance metrics were not provided in the excerpt.
Performance comparisons indicate how ABL and NLY are faring relative to their peers, impacting investor sentiment and potential investment decisions in these sectors.
Abacus Life, Inc. (ABL) has a consensus price target indicating a 57.5% upside potential, with recent upward revisions in earnings estimates suggesting possible near-term gains.
A 57.5% upside potential for Abacus Life, Inc. suggests significant growth opportunities, while revised earnings estimates indicate positive momentum, potentially boosting investor confidence.
Abacus Life, Inc. (ABL) has been upgraded to a Zacks Rank #2 (Buy), indicating increased optimism about its earnings prospects.
Abacus Life's upgrade to Zacks Rank #2 indicates strong earnings potential, likely boosting investor confidence and attracting buying interest in the stock.
Abacus Global Management (NASDAQ: ABL) reported Q1 2025 revenue of $44.1M, over double last year's $21.5M, driven by increased capital deployment and demand for alternative assets.
Abacus Global Management's strong Q1 performance indicates robust growth and demand in alternative assets, enhancing its appeal as an investment and potentially boosting stock value.
Based on our analysis of 5 Wall Street analysts, Abacus Life Inc. (ABL) has a median price target of $14.00. The highest price target is $15.00 and the lowest is $12.00.
According to current analyst ratings, ABL has 5 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $8.19. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict ABL stock could reach $14.00 in the next 12 months. This represents a 70.9% increase from the current price of $8.19. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company purchases and manages life insurance policies, allowing policyholders to sell their policies for immediate cash. This business model provides a financial planning tool, especially for seniors who may no longer require or afford their insurance coverage, thereby generating revenue through the acquisition and management of these policies.
The highest price target for ABL is $15.00 from Matt Howlett at B. Riley Securities, which represents a 83.2% increase from the current price of $8.19.
The lowest price target for ABL is $12.00 from Crispin Love at Piper Sandler, which represents a 46.5% increase from the current price of $8.19.
The overall analyst consensus for ABL is bullish. Out of 5 Wall Street analysts, 5 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $14.00.
Stock price projections, including those for Abacus Life Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.